Adma Biologics: 2Q Earnings Snapshot
RAMSEY, N.J. (AP) _ Adma Biologics Inc. (ADMA) on Thursday reported a loss of $13.2 million in its second quarter.
The Ramsey, New Jersey-based company said it had a loss of 25 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 26 cents per share.
The infectious disease drug developer posted revenue of $6.6 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $4.4 million.
The company’s shares closed at $3.35. A year ago, they were trading at $6.25.